No Impact of Fluconazole to Echinocandins Replacement as First-Line Therapy on the Epidemiology of Yeast Fungemia (Hospital-Driven Active Surveillance, 2004–2017, Paris, France)

Replacement of fluconazole by echinocandins as the first-line therapy for yeast-related fungemia could have an impact on both the mortality rate and the epidemiology of yeast species responsible for candidemia. We analyzed the individual clinical and microbiological data collected through the active...

Descripción completa

Detalles Bibliográficos
Autores principales: Bretagne, Stéphane, Desnos-Ollivier, Marie, Sitbon, Karine, Lortholary, Olivier, Che, Didier, Dromer, Françoise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093410/
https://www.ncbi.nlm.nih.gov/pubmed/33959624
http://dx.doi.org/10.3389/fmed.2021.641965

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093410/
https://www.ncbi.nlm.nih.gov/pubmed/33959624
http://dx.doi.org/10.3389/fmed.2021.641965

Ejemplares similares